|
WDR92 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.366620E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.180820E-04 |
| Normal-vs-Stage2 |
5.645700E-02 |
| Normal-vs-Stage3 |
1.539600E-03 |
| Normal-vs-Stage4 |
7.76090000000895E-05 |
| Stage1-vs-Stage2 |
7.516000E-01 |
| Stage1-vs-Stage3 |
5.547800E-01 |
| Stage1-vs-Stage4 |
2.036600E-01 |
| Stage2-vs-Stage3 |
4.753600E-01 |
| Stage2-vs-Stage4 |
1.688440E-01 |
| Stage3-vs-Stage4 |
3.692800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.023600E-04 |
| Normal-vs-AfricanAmerican |
3.800800E-04 |
| Normal-vs-Asian |
1.859570E-01 |
| Caucasian-vs-AfricanAmerican |
5.941400E-01 |
| Caucasian-vs-Asian |
7.679000E-01 |
| AfricanAmerican-vs-Asian |
5.995200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.81622999999576E-05 |
| Normal-vs-Female |
1.226020E-01 |
| Male-vs-Female |
1.411530E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.78880000000814E-05 |
| Normal-vs-Extreme_Weight |
2.09469999999934E-05 |
| Normal-vs-Obese |
2.795800E-03 |
| Normal-vs-Extreme_Obese |
2.839200E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.831800E-01 |
| Normal_Weight-vs-Obese |
2.625600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.849600E-01 |
| Extreme_Weight-vs-Obese |
2.739000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.413000E-01 |
| Obese-vs-Extreme_Obese |
8.253200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.466000E-01 |
| Normal-vs-Age(41-60Yrs) |
6.976800E-03 |
| Normal-vs-Age(61-80Yrs) |
3.72170000000338E-05 |
| Normal-vs-Age(81-100Yrs) |
6.211400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.444000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.249000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.185700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.775600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.147380E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.640800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.258400E-03 |
| Normal-VS-Type2 PRCC |
3.91799999999165E-07 |
| Normal-VS-KIRP CIMP |
2.047800E-01 |
| Normal-VS-Unclassified PRCC |
1.202800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.442900E-03 |
| Type1 PRCC-VS-KIRP CIMP |
7.635000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.125800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.014380E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.765850E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.426600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.80559999998875E-06 |
| Normal-vs-N1 |
4.689900E-02 |
| Normal-vs-N2 |
1.681700E-02 |
| N0-vs-N1 |
2.251200E-01 |
| N0-vs-N2 |
8.945800E-01 |
| N1-vs-N2 |
5.536000E-01 |
|
|
